Ignite Creation Date:
2024-05-05 @ 6:49 PM
Last Modification Date:
2024-10-26 @ 9:37 AM
Study NCT ID:
NCT00558545
Status:
TERMINATED
Last Update Posted:
2009-12-02
First Post:
2007-11-13
Brief Title:
A Phase 1-2 XIAP Antisense AEG35156 With Weekly Paclitaxel in Patients With Advanced Breast Cancer
Sponsor:
Aegera Therapeutics
Organization:
Aegera Therapeutics
Organization Data
Organization:
Aegera Therapeutics
Class:
INDUSTRY
Study ID:
AEG35156-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Aegera Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Jacques Jolivet VP Clinical
Old Organization:
Aegera Therapeutics Inc